JENNIFER ISHMAEL: Open Payments
NPI 1245570407 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 51 payments from 10 companies in 2025. Trend: 2023 $836 · 2024 $1,112 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $257 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Ardelyx, Inc. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 5 | $51 |
| Celltrion USA Inc. | 3 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $27 |
| PFIZER INC. | 1 | $24 |
Products named: RINVOQ, ENTYVIO, REZDIFFRA, IBSRELA, GATTEX, VOQUEZNA, VEGZELMA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
